Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-29 Sale | 2024-12-03 5:48 pm | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 48,847 | $4.5556 | $222,527 | 294,788 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 08:29 am | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 22,528 | $6.4726 | $145,815 | 330,735 (Direct) | View |
| 2024-07-11 Sale | 2024-07-15 08:35 am | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 20,293 | $5.9734 | $121,218 | 353,263 (Direct) | View |
| 2022-12-08 Purchase | 2022-12-12 4:25 pm | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 15,985 | $1.878 | $30,020 | 40,985 (Direct) | View |
| 2021-07-29 Purchase | 2021-08-02 8:09 pm | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 25,000 | $8 | $200,000 | 25,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-21 Exercise | 2024-11-21 3:07 pm | N/A 2030-10-10 | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 12,900 | $0 | 2,107,603 (Direct) | View |
| 2024-11-21 Exercise | 2024-11-21 3:07 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 12,900 | $1.55 | 2,107,603 (Direct) | View |
| 2023-11-28 Tax Withholding | 2023-11-30 5:00 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 43,443 | $0.9 | 373,556 (Direct) | View |
| 2023-11-26 Option Award | 2023-11-28 4:30 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 180,108 | $0 | 416,999 (Direct) | View |
| 2023-04-28 Option Award | 2023-05-02 5:10 pm | N/A 2033-04-28 | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 180,000 | $0 | 180,000 (Direct) | View |
| 2022-11-28 Option Award | 2022-11-30 6:30 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 195,906 | $0 | 220,906 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-01 6:35 pm | N/A 2032-02-28 | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 330,000 | $0 | 330,000 (Direct) | View |
Ownership | 2021-07-26 9:22 pm | N/A 2030-10-09 | Candel Therapeutics Inc. | CADL | Tak Paul Peter President & CEO | 0 | $0 | 2,073,012 (Direct) | View |